Manufacturer record
Maxwell Life Science Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Maxwell Life Science Pvt. Ltd (Maharashtra) was declared Not of Standard Quality in June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: MT403, Co-Trimoxazole Tablets IP 480mg (exp Dec 2026). CDTL Chennai (CDSCO lab) found it not of standard quality: Dissolution for Sulphamethoxazole. Listed in the June 2025 alert.
Records by type
1 record linked to Maxwell Life Science Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Co-Trimoxazole Tablets IP 480mg | Batch MT403Mfg Jan 2024 · Exp Dec 2026 | Dissolution for SulphamethoxazoleDissolution | CDTL ChennaiCDSCO lab | Jun 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.